Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay
Open Access
- 6 March 2018
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 115 (12), E2849-E2858
- https://doi.org/10.1073/pnas.1722344115
Abstract
Frontotemporal dementia (FTD) is the most common neurodegenerative disorder in individuals under age 60 and has no treatment or cure. Because many cases of FTD result from GRN nonsense mutations, an animal model for this type of mutation is highly desirable for understanding pathogenesis and testing therapies. Here, we generated and characterized GrnR493X knockin mice, which model the most common human GRN mutation, a premature stop codon at arginine 493 (R493X). Homozygous GrnR493X mice have markedly reduced Grn mRNA levels, lack detectable progranulin protein, and phenocopy Grn knockout mice, with CNS microgliosis, cytoplasmic TDP-43 accumulation, reduced synaptic density, lipofuscinosis, hyperinflammatory macrophages, excessive grooming behavior, and reduced survival. Inhibition of nonsense-mediated mRNA decay (NMD) by genetic, pharmacological, or antisense oligonucleotide-based approaches showed that NMD contributes to the reduced mRNA levels in GrnR493X mice and cell lines and in fibroblasts from patients containing the GRNR493X mutation. Moreover, the expressed truncated R493X mutant protein was functional in several assays in progranulin-deficient cells. Together, these findings establish a murine model for in vivo testing of NMD inhibition or other therapies as potential approaches for treating progranulin deficiency caused by the R493X mutation.Funding Information
- HHS | National Institutes of Health (AG023501)
- HHS | National Institutes of Health (GM105718)
- HHS | National Institutes of Health (AG047270)
- HHS | National Institutes of Health (AG047339)
- Center for Integrated Healthcare, U.S. Department of Veterans Affairs (BX002978)
- Bluefield project (Fellowship)
- Consortium for Frontotemporal Dementia Research (N/A)
- Gladstone Institutes (N/A)
- Howard Hughes Medical Institute (N/A)
This publication has 81 references indexed in Scilit:
- Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense SuppressionPLOS ONE, 2013
- Induced Pluripotent Stem Cell Models of Progranulin-Deficient Frontotemporal Dementia Uncover Specific Reversible Neuronal DefectsCell Reports, 2012
- Locus‐specific mutation databases for neurodegenerative brain diseasesHuman Mutation, 2012
- Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation DosageAmerican Journal of Human Genetics, 2012
- Core features of frontotemporal dementia recapitulated in progranulin knockout miceNeurobiology of Disease, 2012
- Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar DegenerationArchives of Neurology, 2011
- The Pioneer Round of Translation: Features and FunctionsCell, 2010
- The Spectrum of Mutations in ProgranulinArchives of Neurology, 2010
- Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypesNeuroscience Letters, 2010
- The Many Pathways of RNA DegradationCell, 2009